Akebia Therapeutics Inc. Watch

from S-3 8 pages Form of Subordinated Note

from S-3 8 pages Form of Senior Note

from S-3 65 pages Akebia Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities

from S-3 61 pages Akebia Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities

from 10-K 16 pages Warrant Akebia Therapeutics, Inc

from 10-K 18 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Investment Agreement by and Between Vifor (International) Ltd. and Akebia Therapeutics, Inc. Dated as of February 18, 2022

from S-3ASR 8 pages Form of Subordinated Note

from S-3ASR 8 pages Form of Senior Note

from S-3ASR 62 pages Akebia Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities

from S-3ASR 59 pages Akebia Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities

from 10-K 4 pages Description of Capital Stock

from 10-K 3 pages Description of Capital Stock

from S-8 1 page Amendment No. 1 to the Akebia Therapeutics, Inc. 2014 Incentive Plan

from 10-K 7 pages Amendment No. 1 to Fourth Amended and Restated Investors’ Rights Agreement

from S-3ASR 7 pages Amendment No. 1 to Fourth Amended and Restated Investors’ Rights Agreement

from S-8 8 pages Akebia Therapeutics, Inc. Inducement Award Non-Statutory Stock Option Agreement

from S-8 8 pages Akebia Therapeutics, Inc. Officer Inducement Award Non-Statutory Stock Option Agreement

from 10-Q 21 pages Confidential Investment Agreement by and Between Vifor (International) Ltd. and Akebia Therapeutics, Inc. Dated as of May 12, 2017

from 10-Q 15 pages Confidential

from S-8 10 pages This Prospectus Relates to Shares of Common Stock (“Stock”) That Akebia Therapeutics, Inc. (Referred to as the “Company” or “We” in This Prospectus) May Issue to Our and Our Affiliates’ Key Employees, Directors, Consultants, and Advisors Under Awards Granted Pursuant to Our Inducement Award Program (Our “Inducement Award Program”) to Provide an Inducement Material to the Recipient’s Decision to Enter Into Employment With US (“Inducement Awards”). We Are Delivering This Document to You Because You Have Been Granted an Inducement Award Pursuant to the Inducement Award Program Approved by Our Board of Directors (The “Board”). the Details of Your Inducement Award, Including the Number of Shares of Stock Covered by Your Award, the Exercise Price and the Vesting Terms of Your Award, and Other Information Relating to Your Award, Are Included in Your Award Agreement. Inducement Awards Are Not Granted Under Our 2014 Incentive Plan (The “Plan”), but Are Subject to Terms and Conditions That Are the Same as the Terms and Conditions of the Plan, as Modified by the Board as Described Herein. Please Read This Document, Your Award Agreement and the Plan for a Complete Understanding of Your Award. This Document Contains a Summary Intended to Familiarize You With the Terms and Conditions of the Inducement Award Program. the Summary Is Qualified by Reference to the Text of the Plan, a Copy of Which Has Been Made Available to You. Shares of Our Stock Are Listed on the NASDAQ Global Market Under the Symbol “AKBA”. the SEC and State Securities Regulators Have Not Approved or Disapproved These Securities, or Determined if This Prospectus Is Truthful or Complete. Any Representation to the Contrary Is a Criminal Offense. We Have Provided You With This Document in Accordance With Rule 428(b) and Form S-8 of the Rules and Regulations of the SEC Promulgated Under the Securities Act of 1933